Hyperprogressive disease during atezolizumab plus bevacizumab treatment in patients with advanced hepatocellular carcinoma from Japanese real-world practice
日本真实世界实践中晚期肝细胞癌患者接受阿特珠单抗联合贝伐珠单抗治疗期间出现超进展性疾病的情况
期刊:BMC Gastroenterology
影响因子:2.6
doi:10.1186/s12876-023-02731-5
Yumita, Sae; Ogasawara, Sadahisa; Nakagawa, Miyuki; Maruta, Susumu; Okubo, Tomomi; Itokawa, Norio; Iino, Yotaro; Obu, Masamichi; Haga, Yuki; Seki, Atsuyoshi; Kogure, Tadayoshi; Ishino, Takamasa; Ogawa, Keita; Fujiwara, Kisako; Iwanaga, Terunao; Fujita, Naoto; Sakuma, Takafumi; Kojima, Ryuta; Kanzaki, Hiroaki; Koroki, Keisuke; Inoue, Masanori; Kobayashi, Kazufumi; Kiyono, Soichiro; Nakamura, Masato; Kanogawa, Naoya; Saito, Tomoko; Kondo, Takayuki; Nakagawa, Ryo; Nakamoto, Shingo; Muroyama, Ryosuke; Chiba, Tetsuhiro; Itobayashi, Ei; Atsukawa, Masanori; Koma, Yoshihiro; Azemoto, Ryosaku; Ito, Kenji; Mizumoto, Hideaki; Kato, Jun; Kato, Naoya
